BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36026500)

  • 1. Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil.
    Diniz AN; Moura LNF; Cruz DSG; Oliveira Junior CA; Figueiredo HCP; Cunha JLR; Vilela EG; Kuijper EJ; Wilcox MH; Lobato FCF; Silva ROS
    PLoS One; 2022; 17(8):e0273013. PubMed ID: 36026500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics.
    Shaw HA; Preston MD; Vendrik KEW; Cairns MD; Browne HP; Stabler RA; Crobach MJT; Corver J; Pituch H; Ingebretsen A; Pirmohamed M; Faulds-Pain A; Valiente E; Lawley TD; Fairweather NF; Kuijper EJ; Wren BW
    Clin Microbiol Infect; 2020 Apr; 26(4):492-498. PubMed ID: 31525517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of Clostridioides (previously Clostridium) difficile isolates from a university hospital in Minas Gerais, Brazil.
    Diniz AN; de Oliveira Júnior CA; Vilela EG; Figueiredo HCP; Rupnik M; Wilcox MH; Fawley WN; Blanc DS; Faria Lobato FC; Silva ROS
    Anaerobe; 2019 Apr; 56():34-39. PubMed ID: 30703440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-toxin
    Anwar F; Roxas BAP; Shehab KW; Ampel NM; Viswanathan VK; Vedantam G
    Emerg Microbes Infect; 2022 Dec; 11(1):1982-1993. PubMed ID: 35880487
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
    Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Clostridioides difficile colonization at admission to the hospital: a multi-centre study.
    Crobach MJT; Hornung BVH; Verduin C; Vos MC; Hopman J; Kumar N; Harmanus C; Sanders I; Terveer EM; Stares MD; Lawley TD; Kuijper EJ
    Clin Microbiol Infect; 2023 Jul; 29(7):891-896. PubMed ID: 36871826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clostridioides difficile strains from animals and humans: First results after introduction of C. difficile molecular typing and characterization at the Istituto Zooprofilattico Sperimentale of Piemonte, Liguria e Valle d'Aosta, Italy.
    Tramuta C; Spigaglia P; Barbanti F; Bianchi DM; Boteva C; Di Blasio A; Zoppi S; Zaccaria T; Proroga YTR; Chiavacci L; Dondo A; Decastelli L
    Comp Immunol Microbiol Infect Dis; 2021 Apr; 75():101623. PubMed ID: 33607397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and epidemiologic study of Clostridium difficile reveals unusual heterogeneity in clinical strains circulating in different regions in Portugal.
    Santos A; Isidro J; Silva C; Boaventura L; Diogo J; Faustino A; Toscano C; Oleastro M
    Clin Microbiol Infect; 2016 Aug; 22(8):695-700. PubMed ID: 27091093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.
    Du T; Choi KB; Silva A; Golding GR; Pelude L; Hizon R; Al-Rawahi GN; Brooks J; Chow B; Collet JC; Comeau JL; Davis I; Evans GA; Frenette C; Han G; Johnstone J; Kibsey P; Katz KC; Langley JM; Lee BE; Longtin Y; Mertz D; Minion J; Science M; Srigley JA; Stagg P; Suh KN; Thampi N; Wong A; Hota SS
    Emerg Infect Dis; 2022 Jun; 28(6):1128-1136. PubMed ID: 35470794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ribotype
    Gu W; Wang W; Li W; Li N; Wang Y; Zhang W; Lu C; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
    Emerg Microbes Infect; 2021 Dec; 10(1):687-699. PubMed ID: 33682630
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridioides (Clostridium) difficile isolated from paediatric patients in Western Australia 2019-2020.
    Perumalsamy S; Lim SC; Riley TV
    Pathology; 2022 Jun; 54(4):460-465. PubMed ID: 35125203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic surveillance of
    Newcomer EP; Fishbein SRS; Zhang K; Hink T; Reske KA; Cass C; Iqbal ZH; Struttmann EL; Burnham C-AD; Dubberke ER; Dantas G
    mBio; 2024 Mar; 15(3):e0330023. PubMed ID: 38329369
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France.
    Cassir N; Fahsi N; Durand G; Lagier JC; Raoult D; Fournier PE
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea.
    Li C; Harmanus C; Zhu D; Meng X; Wang S; Duan J; Liu S; Fu C; Zhou P; Liu R; Wu A; Kuijper EJ; Smits WK; Fu L; Sun X
    Emerg Microbes Infect; 2018 Dec; 7(1):211. PubMed ID: 30542069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI-TOF MS: An alternative approach for ribotyping Clostridioides difficile isolates in Brazil.
    Carneiro LG; Pinto TCA; Moura H; Barr J; Domingues RMCP; Ferreira EO
    Anaerobe; 2021 Jun; 69():102351. PubMed ID: 33621659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain.
    Lim SK; Stuart RL; Mackin KE; Carter GP; Kotsanas D; Francis MJ; Easton M; Dimovski K; Elliott B; Riley TV; Hogg G; Paul E; Korman TM; Seemann T; Stinear TP; Lyras D; Jenkin GA
    Clin Infect Dis; 2014 Jun; 58(12):1723-30. PubMed ID: 24704722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018.
    Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Clostridioides difficile in dogs (Canis familiaris) with gastrointestinal disorders in Rio de Janeiro.
    Leite S; Cotias C; Rainha KC; Santos MG; Penna B; F Moraes RF; Harmanus C; Smits WK; Ferreira EO
    Anaerobe; 2023 Oct; 83():102765. PubMed ID: 37573963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.